L-Y Shih

1.2k total citations
16 papers, 896 citations indexed

About

L-Y Shih is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, L-Y Shih has authored 16 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in L-Y Shih's work include Acute Myeloid Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Angiogenesis and VEGF in Cancer (4 papers). L-Y Shih is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Angiogenesis and VEGF in Cancer (4 papers). L-Y Shih collaborates with scholars based in Taiwan, United States and Japan. L-Y Shih's co-authors include Wu Jh, M-C. Kuo, Chih‐Fen Huang, Lee Ct, Po Dunn, Ching‐Lung Lai, T-H Lin, HC Liu, I‐J Hung and S-H Chen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Leukemia.

In The Last Decade

L-Y Shih

16 papers receiving 874 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L-Y Shih Taiwan	13	505	432	287	154	143	16	896
Hidemitsu Kurosawa Japan	14	339 0.7×	373 0.9×	176 0.6×	169 1.1×	146 1.0×	59	827
S. Ridge United Kingdom	6	441 0.9×	263 0.6×	161 0.6×	95 0.6×	113 0.8×	7	659
Seppo Pakkala Finland	15	285 0.6×	451 1.0×	58 0.2×	78 0.5×	110 0.8×	33	757
Christine Ragu France	11	539 1.1×	419 1.0×	197 0.7×	102 0.7×	146 1.0×	15	909
Jinlan Pan China	13	369 0.7×	234 0.5×	177 0.6×	115 0.7×	68 0.5×	104	603
Teresa Larson United Kingdom	7	368 0.7×	629 1.5×	65 0.2×	204 1.3×	135 0.9×	8	943
Amy Billet United States	7	117 0.2×	127 0.3×	169 0.6×	104 0.7×	143 1.0×	8	580
Maddalena Paganin Italy	13	333 0.7×	321 0.7×	66 0.2×	404 2.6×	121 0.8×	18	762
N. Horvath United States	9	417 0.8×	126 0.3×	95 0.3×	36 0.2×	240 1.7×	16	660
Ifat Geron United States	13	230 0.5×	591 1.4×	150 0.5×	48 0.3×	117 0.8×	25	1.0k

Countries citing papers authored by L-Y Shih

Since Specialization

Citations

This map shows the geographic impact of L-Y Shih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L-Y Shih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L-Y Shih more than expected).

Fields of papers citing papers by L-Y Shih

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L-Y Shih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L-Y Shih. The network helps show where L-Y Shih may publish in the future.

Co-authorship network of co-authors of L-Y Shih

This figure shows the co-authorship network connecting the top 25 collaborators of L-Y Shih. A scholar is included among the top collaborators of L-Y Shih based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L-Y Shih. L-Y Shih is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

Liu, HC, S-H Chen, I‐J Hung, et al.. (2015). NUDT15 gene polymorphism related to mercaptopurine intolerance in Taiwan Chinese children with acute lymphoblastic leukemia. The Pharmacogenomics Journal. 16(6). 536–539. 73 indexed citations

2.

Weekes, Colin D., Muralidhar Beeram, Anthony W. Tolcher, et al.. (2014). A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors. Investigational New Drugs. 32(4). 653–660. 72 indexed citations

3.

Patnaik, Amita, Patricia LoRusso, Wells A. Messersmith, et al.. (2014). A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 73(5). 951–960. 61 indexed citations

4.

Darbonne, Walter C., Xing Du, Punita Dhawan, et al.. (2011). Mechanism for platelet reduction in anti-neuropilin-1 (MNRP1685A)–treated phase I patients.. Journal of Clinical Oncology. 29(15_suppl). e13598–e13598. 10 indexed citations

5.

Chang, Hung, et al.. (2011). Collision in the colon: concurrent adenocarcinoma and diffuse large B-cell lymphoma in the same tumour.. PubMed. 66(4). 302–4. 17 indexed citations

6.

Weekes, Colin D., P. LoRusso, L-Y Shih, et al.. (2011). A phase Ib study for MNRP1685A (anti-NRP1) administered intravenously with bevacizumab with or without paclitaxel to patients with advanced solid tumors.. Journal of Clinical Oncology. 29(15_suppl). 3050–3050. 11 indexed citations

7.

Kuo, M-C., et al.. (2009). RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation. Leukemia. 23(8). 1426–1431. 114 indexed citations

8.

Shih, L-Y, Chih‐Fen Huang, Young‐Tae Chang, et al.. (2007). Cooperating mutations of receptor tyrosine kinases and Ras genes in childhood core-binding factor acute myeloid leukemia and a comparative analysis on paired diagnosis and relapse samples. Leukemia. 22(2). 303–307. 60 indexed citations

9.

Shih, L-Y, et al.. (2006). AML patients with CEBPα mutations mostly retain identical mutant patterns but frequently change in allelic distribution at relapse: a comparative analysis on paired diagnosis and relapse samples. Leukemia. 20(4). 604–609. 41 indexed citations

10.

Shih, L-Y, Wu Jh, Po Dunn, et al.. (2005). Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement. Leukemia. 20(2). 218–223. 83 indexed citations

11.

Sakajiri, Sakura, James O’Kelly, Dong Yin, et al.. (2005). Dlk1 in normal and abnormal hematopoiesis. Leukemia. 19(8). 1404–1410. 78 indexed citations

12.

Shih, L-Y, et al.. (2004). Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia. Leukemia. 18(3). 466–475. 111 indexed citations

13.

Shih, L-Y, I‐J Hung, S-H Chen, et al.. (2003). FLT3-TKD mutation in childhood acute myeloid leukemia. Leukemia. 17(5). 883–886. 57 indexed citations

14.

Shih, L-Y & Lee Ct. (1994). Identification of masked polycythemia vera from patients with idiopathic marked thrombocytosis by endogenous erythroid colony assay. Blood. 83(3). 744–748. 5 indexed citations

15.

Shih, L-Y & Lee Ct. (1994). Identification of masked polycythemia vera from patients with idiopathic marked thrombocytosis by endogenous erythroid colony assay. Blood. 83(3). 744–748. 75 indexed citations

16.

Shih, L-Y, et al.. (1993). The effects of boric acid (BA) on testicular cells in culture. Reproductive Toxicology. 7(4). 321–331. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact